MXPA02009275A - Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos. - Google Patents

Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.

Info

Publication number
MXPA02009275A
MXPA02009275A MXPA02009275A MXPA02009275A MXPA02009275A MX PA02009275 A MXPA02009275 A MX PA02009275A MX PA02009275 A MXPA02009275 A MX PA02009275A MX PA02009275 A MXPA02009275 A MX PA02009275A MX PA02009275 A MXPA02009275 A MX PA02009275A
Authority
MX
Mexico
Prior art keywords
physiologically active
active ingredients
high pressure
dispersions containing
containing physiologically
Prior art date
Application number
MXPA02009275A
Other languages
English (en)
Inventor
James M Wilmott
Original Assignee
Collaborative Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collaborative Technologies Inc filed Critical Collaborative Technologies Inc
Publication of MXPA02009275A publication Critical patent/MXPA02009275A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)

Abstract

Se describen metodos para preparar dispersiones que contienen modificadores esteticos o ingredientes fisiologicamente activos y que contienen opcionalmente vehiculos, incluyendo solventes. Las dispersiones se preparan utilizando metodos de alta presion/alto esfuerzo cortante.
MXPA02009275A 2000-03-23 2001-03-23 Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos. MXPA02009275A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19150800P 2000-03-23 2000-03-23
PCT/US2001/009272 WO2001070197A2 (en) 2000-03-23 2001-03-23 Method for preparing high pressure/high shear dispersions containing physiologically active ingredients

Publications (1)

Publication Number Publication Date
MXPA02009275A true MXPA02009275A (es) 2004-09-06

Family

ID=22705764

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009275A MXPA02009275A (es) 2000-03-23 2001-03-23 Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.

Country Status (9)

Country Link
EP (1) EP1267830B1 (es)
JP (1) JP2003527411A (es)
AT (1) ATE432063T1 (es)
AU (1) AU2001245947A1 (es)
CA (1) CA2403704C (es)
DE (1) DE60138804D1 (es)
ES (1) ES2327901T3 (es)
MX (1) MXPA02009275A (es)
WO (1) WO2001070197A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US6783766B2 (en) 2002-03-06 2004-08-31 Dow Global Technologies Inc. Process for preparing a cosmetic formulation
WO2008010788A2 (en) * 2005-07-18 2008-01-24 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
JP5292304B2 (ja) 2006-12-01 2013-09-18 アンテリオス， インコーポレイテッド ペプチドナノ粒子およびその使用
US20100150994A1 (en) 2006-12-01 2010-06-17 Anterios, Inc. Amphiphilic entity nanoparticles
US20080206351A1 (en) * 2007-02-23 2008-08-28 Conopco, Inc., D/B/A Unilever Malodor Reduction of Cosmetic Products
KR20100050443A (ko) 2007-05-31 2010-05-13 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
DE102011117364A1 (de) * 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
JP2019530737A (ja) 2016-08-23 2019-10-24 アコーオス インコーポレイテッド ヒト対象において非加齢性聴力障害を治療するための組成物および方法
KR102487144B1 (ko) 2016-11-21 2023-01-12 에이리온 테라퓨틱스, 인코포레이티드 큰 물질의 경피 전달
CA3047424A1 (en) 2016-12-22 2018-06-28 Unilever Plc Stabilization of cosmetic compositions comprising fish oils and hydroxylated fatty acids and/or its derivatives
CA3168055A1 (en) 2020-02-21 2021-08-26 Emmanuel John Simons Compositions and methods for treating non-age-associated hearing impairment in a human subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5914102A (en) * 1997-11-26 1999-06-22 Schering-Plough Healthcare Products, Inc. High SPF perspiration-resistant sunscreen
DE60119693T2 (de) * 2000-01-31 2007-04-26 Engelhard Corp. Tensidfreie topische zusammensetzungen und verfahren zur schnellen herstellung davon

Also Published As

Publication number Publication date
DE60138804D1 (de) 2009-07-09
WO2001070197A3 (en) 2002-05-16
ATE432063T1 (de) 2009-06-15
CA2403704C (en) 2012-04-10
EP1267830B1 (en) 2009-05-27
ES2327901T3 (es) 2009-11-05
JP2003527411A (ja) 2003-09-16
AU2001245947A1 (en) 2001-10-03
CA2403704A1 (en) 2001-09-27
WO2001070197A2 (en) 2001-09-27
EP1267830A2 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
MXPA02009275A (es) Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
AU2525401A (en) Use of an extract of at least one vaccinium-type plant as an anti-glycation agent
WO2002030463A3 (en) Reduced-viscosity concentrated protein formulations
EP1160645A3 (en) Method and apparatus for establishing a security policy, and method and apparatus for supporting establishment of security policy
MXPA04005517A (es) Composiciones farmaceuticas bajo forma de gel o solucion a base de dihidrotestosterona, su metodo de preparacion y sus usos.
HK1044945A1 (en) 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use.
PL1643833T3 (pl) Formulacje agrochemiczne
MXPA02010927A (es) Metodo y sistema para fabricar productos de tisu, y productos hechos por el mismo.
WO2003057163A3 (en) Methods for preparing immunoconjugates
WO2000020470A3 (en) Aqueous dispersions
WO2002049452A3 (en) Flavour concentrates
PL346463A1 (en) Method of obtaining derivatives of resorcinol, method of obtaining novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, method of obtaining novel derivatives of 1,3-cyclohezandione, method of obtaining novel derivatives of 2-cyclohexanone, novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, novel derivatives of 1,3-cyclohexanodione, and novel derivatives of 2-cyclohexenonea
IL154776A0 (en) Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof
TW200501943A (en) Escitalopram hydrobromide and a method for the preparation thereof
AU2001273999A1 (en) Fluorescein isothiocyanate (fitc) sinistrin, its production and use
WO2001005414A8 (fr) Extrait de polysaccharide d'une proteine d'algue et son utilisation
AU4288300A (en) Unsupported flat linoleum structure and method of producing same
AU2001234616A1 (en) Vaccine composition, process and methods
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
AP2003002874A0 (en) Echinocandin derivatives, preparation method and application as anti-fungal agents.
AU2002328285A1 (en) Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.
HK1036070A1 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them.
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
NL1017717A1 (nl) Gecombineerde plantencoagulaatsamenstelling, werkwijze voor de bereiding ervan en toepassing ervan.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ENGELHARD CORPORATION

FA Abandonment or withdrawal